Filter Results:
(997)
Show Results For
- All HBS Web
(997)
- News (154)
- Research (695)
- Events (23)
- Multimedia (1)
- Faculty Publications (435)
Show Results For
- All HBS Web
(997)
- News (154)
- Research (695)
- Events (23)
- Multimedia (1)
- Faculty Publications (435)
- 23 Jan 2015
- News
How U.S. laws protecting America’s best ideas are killing innovation
- 15 May 2020
- News
Innovation Can’t Be Forced, but It Can Be Quashed
- November 2016
- Case
Transformation at Eli Lilly & Co. (A)
By: William R. Kerr and Alexis Brownell
Faced with the imminent loss of 40% of its revenues due to patent expirations, pharma giant Eli Lilly sets out on a dramatic transformation process in 2009. The case considers how Lilly restructured the organization into business areas to aid better decision-making,... View Details
Keywords: Eli Lilly; Restructuring; R&D; Transformation; Organizational Change and Adaptation; Organizational Structure; Pharmaceutical Industry; Indianapolis
Kerr, William R., and Alexis Brownell. "Transformation at Eli Lilly & Co. (A)." Harvard Business School Case 817-070, November 2016.
- August 2008 (Revised May 2009)
- Background Note
Note on Trade Secrets and Covenants not to Compete: Comparison of Law in the United States and the European Union
By: Robert C. Pozen and Megan Barbero
This note details the use and treatment of Covenants not to Compete in the United States, United Kingdom and France to compete or trade secrets versus patents as alternative ways to protect a business' intellectual property. View Details
Pozen, Robert C., and Megan Barbero. "Note on Trade Secrets and Covenants not to Compete: Comparison of Law in the United States and the European Union." Harvard Business School Background Note 309-024, August 2008. (Revised May 2009.)
- Article
Small Worlds and Regional Innovation
Small-world networks have attracted much theoretical attention and are widely thought to enhance creativity. Yet empirical studies of their evolution and evidence of their benefits remain scarce. We develop and exploit a novel database on patent coauthorship to... View Details
Keywords: Geographic Location; Collaborative Innovation and Invention; Patents; Performance Productivity; Creativity; Social and Collaborative Networks
Fleming, Lee, Charles King III, and Adam Juda. "Small Worlds and Regional Innovation." Organization Science 18, no. 6 (November–December 2007).
- May 2009 (Revised August 2013)
- Case
The DiagnoFirst Opportunity
By: Robert C. Pozen and Rukmini Balu
John Mason, a principle at Oldwell Partners, was facing a decision of whether or not to invest in DiagnoFirst, a molecular diagnostics firm. DiagnoFirst's key product was a genetic test that identified a subset of prostate cancer patients with a high risk of clinical... View Details
Keywords: Genetic Engineering; Genetically Modified; Genomics; Venture Capital; Patents; Genetics; Decision Choices and Conditions; Laws and Statutes; Investment; Science-Based Business; Biotechnology Industry
Pozen, Robert C., and Rukmini Balu. "The DiagnoFirst Opportunity." Harvard Business School Case 309-112, May 2009. (Revised August 2013.)
- January 2009
- Article
Spatial Diversity in Invention: Evidence from the Early R&D Labs
By: Tom Nicholas
This article uses historical data on inventor and firm R&D lab locations to examine the technological and geographic structure of corporate knowledge capital accumulation during a formative period in the organization of US innovation. Despite the localization of... View Details
Keywords: Factories, Labs, and Plants; Geographic Location; Innovation and Invention; Patents; Knowledge Acquisition; Research and Development; United States
Nicholas, Tom. "Spatial Diversity in Invention: Evidence from the Early R&D Labs." Journal of Economic Geography 9, no. 1 (January 2009).
- 26 Sep 2018
- Working Paper Summaries
Shifting Centers of Gravity: Host Country versus Headquarters Influences on MNC Subsidiary Knowledge Inheritance
- January 2011
- Supplement
Matrix Capital Management (B)
By: Malcolm P. Baker and David Lane
Ben Balbale, a partner at hedge fund Matrix Capital, must decide whether to exit their investment in Rovi Corporation, a company with a diverse portfolio of patents used primarily for digital interactive guides. Rovi's shares are up over 50% from the time Balbale... View Details
Keywords: Public Ownership; Cash Flow; Management Analysis, Tools, and Techniques; Investment Funds; Financial Strategy; Valuation; Partners and Partnerships; Markets; Performance Efficiency; Patents; Stock Shares; Decisions; Financial Services Industry
Baker, Malcolm P., and David Lane. "Matrix Capital Management (B)." Harvard Business School Supplement 211-048, January 2011.
- 05 Dec 2006
- First Look
First Look: December 5, 2006
Working PapersThe Industry R&D Survey — Patent Database Link Project Authors:William R. Kerr and Shihe Fu Abstract This paper details the construction of a firm-year panel dataset combining the NBER View Details
Keywords: Sean Silverthorne
- January 2021
- Article
Commuting and Innovation: Are Closer Inventors More Productive?
By: Hongyu Xiao, Andy Wu and Jaeho Kim
We estimate the causal effect of workplace–home commuting distance on inventor productivity. We construct a novel panel of U.S. inventors with precisely measured workplace–home distances and inventor-level productivity. Our identification strategy exploits firm office... View Details
Keywords: Commuting; Proximity; Inventors; Innovation; Relocation; Telecommuting; Geographic Location; Technological Innovation; Innovation and Management; Innovation Strategy; United States
Xiao, Hongyu, Andy Wu, and Jaeho Kim. "Commuting and Innovation: Are Closer Inventors More Productive?" Art. 103300. Journal of Urban Economics 121 (January 2021).
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- 31 Jul 2018
- Working Paper Summaries
How Does Product Liability Risk Affect Innovation? Evidence from Medical Implants
Keywords: by Alberto Galasso and Hong Luo
Agglomeration of Invention in the Bay Area: Not Just ICT
Does invention agglomerate, and if so, where does it agglomerate? In this paper we examine changes in patterns of agglomeration in invention over time, using data on patent applications from all granted US patents. View Details
- May 2017
- Article
Immigration and the Rise of American Ingenuity
By: Ufuk Akcigit, John Grigsby and Tom Nicholas
We build on the analysis in Akcigit, Grigsby, and Nicholas (2017) by using U.S. patent and census data to examine the relationship between immigration and innovation. We construct a measure of foreign born expertise and show that technology areas where immigrant... View Details
Akcigit, Ufuk, John Grigsby, and Tom Nicholas. "Immigration and the Rise of American Ingenuity." American Economic Review: Papers and Proceedings 107, no. 5 (May 2017): 327–331.
- March 2016
- Case
N12 Technologies: Building an Organization and Building a Business
By: David A. Garvin and Aldo Sesia
N12 Technologies was a startup founded in 2010 that employed nanotechnology to manufacture a patented material to improve the performance of carbon fiber composites, which were used in a wide variety of products, ranging from bicycles to automobiles to aircraft parts.... View Details
Keywords: Startup; Organizational Structure; Nanotechnology; Business Processes; Organizational Change and Adaptation; Organizational Design; Management Systems; Commercialization; Industrial Products Industry; Manufacturing Industry; Auto Industry; Bicycle Industry; Transportation Industry; United States
Garvin, David A., and Aldo Sesia. "N12 Technologies: Building an Organization and Building a Business." Harvard Business School Case 316-002, March 2016.
- October 2016 (Revised September 2017)
- Case
The CRISPR-Cas9 Quarrel
By: Richard G. Hamermesh and Matthew G. Preble
In mid-2016, the Broad Institute and the University of California, Berkeley were in the middle of a contentious patent dispute over which entity controlled a breakthrough gene editing technology called CRISPR-Cas9. With CRISPR-Cas9, scientists might soon be able to... View Details
Keywords: CRISPR; Broad Institute; University Of California Berkeley; Intellectual Property; Patents; Law; Lawsuits and Litigation; Science; Genetics; Entrepreneurship; Biotechnology Industry; United States
Hamermesh, Richard G., and Matthew G. Preble. "The CRISPR-Cas9 Quarrel." Harvard Business School Case 817-020, October 2016. (Revised September 2017.)
- 25 Jul 2012
- News